Financials data is unavailable for this security.
View more
Year on year Precision BioSciences Inc grew revenues 94.15% from 25.10m to 48.73m while net income improved from a loss of 111.64m to a smaller loss of 61.32m.
Gross margin | -- |
---|---|
Net profit margin | 15.28% |
Operating margin | -21.58% |
Return on assets | 7.23% |
---|---|
Return on equity | 24.44% |
Return on investment | 9.00% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Precision BioSciences Inc fell by 72.90m. However, Cash Flow from Investing totalled 5.83m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 84.11m for operations while cash generated from financing totalled 5.39m.
Cash flow per share | 2.69 |
---|---|
Price/Cash flow per share | 4.09 |
Book value per share | 8.67 |
---|---|
Tangible book value per share | 8.62 |
More ▼
Balance sheet in USDView more
Current ratio | 9.22 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.3435 |
---|---|
Total debt/total capital | 0.2557 |
More ▼